🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yang Liu

Sichuan University

ORCID: 0000-0003-3957-2754

Also affiliated with Guangxi Normal University, West China Hospital of Sichuan University, Veracyte (United States), Beibu Gulf University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Basal-luminal subtyping of localized high-risk prostate cancer and benefit of adding docetaxel to definitive radiotherapy with androgen suppression in the NRG Oncology/RTOG 0521 phase III trial.”.

Basal-luminal subtyping of localized high-risk prostate cancer and benefit of adding docetaxel to definitive radiotherapy with androgen suppression in the NRG Oncology/RTOG 0521 phase III trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5094
N/A
0DataRank · unranked
3 citations

James A. Proudfoot, Elai Davicioni, Yang Liu, Daniel E. Spratt, Felix Y. Feng +15 more